Salvador Martín‐Algarra

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Axel Hauschild, Jean‐Jacques Grob, Lev Demidov et al. · The Lancet · 2012 · 2.9K citations

Oncology, Braf-mutated Metastatic Melanoma, Melanoma +6

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov et al. · Cell · 2017 · 2.5K citations · Full text

Microenvironment Evolution, Tumor Immunology, Cancer Immunosurveillance +6

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients

Miguel F. Sanmamed, José Luis Perez‐Gracia, Kurt A. Schalper et al. · Annals of Oncology · 2017 · 442 citations · Full text

Cancer Immunosurveillance, Anti-pd-1 Treatment, Medicine +8

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Amod A. Sarnaik, Omid Hamid, Nikhil I. Khushalani et al. · Journal of Clinical Oncology · 2021 · 373 citations · Full text

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko et al. · Cancer Cell · 2020 · 361 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Melanoma +7